SynthesisBreast cancer (Tokyo, Japan)2024

Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price.

Julia Caroline Michaeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.